DOCTORS'
Medical Case Studies
DOCTORS'
Medical Case Studies
Nimotuzumab (EGFR antibody)
Nimotuzumab
Nimotuzumab (BIOMAb EGFR, Biocon, India; TheraCIM, CIMYM Biosciences, Canada; Theraloc, Oncoscience, Europe, CIMAher, Center of Molecular Immunology, Havana, Cuba) is a humanized monoclonal antibody used to treat squamous cell carcinomas of the head and neck, recurrent or refractory high grade malignant glioma, anaplastic astrocytomas, glioblastomas and diffuse intrinsic pontine glioma. Like cetuximab, nimotuzumab binds to the epidermal growth factor receptor (EGFR), a signalling protein that normally controls cell division. In some cancers, this receptor is altered to cause uncontrolled cell division, a hallmark of cancer...
Nimotuzumab (EGFR antibody) - List of case studies
- Drugs
-
Nexium Nicetile Nicoboxil Nimesulide Nimotuzumab (EGFR antibody) Nitrates Nitroglycerine containing medications ...
- Diffuse Intra-Axial expansive Lesion of the Enchephalic Trunk not surgically investigated_4
-
child has started experimental treatment with the medicine nimotuzumab to be followed with conventional radiotherapy. ... steroid therapy, Decadron, Soldesam, Nexium, Nimotuzumab (EGFR antibody), dexamethasone, steroid for vasogenic edema, arsenic trioxide, ...
- Diffuse Intra-Axial expansive Lesion of the Enchephalic Trunk
-
The patient started an experimental treatment with Nimotuzumab, and Radiation therapy is planned to continue with Nimotuzumab. ... steroid therapy, Decadron, Soldesam, Nexium, Nimotuzumab (EGFR antibody), chemotherapies, temozolomide, erlotonib, rapamycin, ...